Therefore, loss of ZBTB7A may facilitate the onset of t (8;21) AML, and that RUNX1-RUNX1T1-rearranged leukemia might be mimicked by glycolytic inhibitors because lack of ZBTB7A can enhance glycolysis [15]. The gene discussed is RUNX1; the disease is acute myeloid leukemia.